Richard Bernstein Advisors LLC increased its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 47.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,938 shares of the healthcare conglomerate’s stock after buying an additional 942 shares during the quarter. Richard Bernstein Advisors LLC’s holdings in UnitedHealth Group were worth $721,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in the stock. Argent Trust Co grew its stake in UnitedHealth Group by 8.3% in the 4th quarter. Argent Trust Co now owns 13,911 shares of the healthcare conglomerate’s stock valued at $3,066,000 after purchasing an additional 1,061 shares during the period. Alps Advisors Inc. bought a new position in UnitedHealth Group in the 1st quarter valued at $280,000. First Long Island Investors LLC grew its stake in UnitedHealth Group by 1.1% in the 1st quarter. First Long Island Investors LLC now owns 26,401 shares of the healthcare conglomerate’s stock valued at $5,650,000 after purchasing an additional 300 shares during the period. Capital Advisors Inc. OK grew its stake in UnitedHealth Group by 60.9% in the 1st quarter. Capital Advisors Inc. OK now owns 72,298 shares of the healthcare conglomerate’s stock valued at $15,472,000 after purchasing an additional 27,359 shares during the period. Finally, KHP Capital LLC bought a new position in UnitedHealth Group in the 1st quarter valued at $164,000. Institutional investors and hedge funds own 85.39% of the company’s stock.
A number of brokerages have issued reports on UNH. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, June 19th. Cantor Fitzgerald restated a “buy” rating and issued a $300.00 price objective on shares of UnitedHealth Group in a research note on Thursday, July 5th. BMO Capital Markets upped their price objective on UnitedHealth Group from $285.00 to $300.00 and gave the company a “positive” rating in a research note on Thursday, June 21st. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 11th. Finally, SunTrust Banks assumed coverage on UnitedHealth Group in a research note on Monday, June 11th. They set a “buy” rating and a $300.00 price target for the company. Two equities research analysts have rated the stock with a hold rating and twenty-one have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $272.43.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 17th. The healthcare conglomerate reported $3.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.04 by $0.10. The business had revenue of $56.09 billion for the quarter, compared to analysts’ expectations of $56.10 billion. UnitedHealth Group had a return on equity of 22.79% and a net margin of 5.55%. The firm’s quarterly revenue was up 12.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.46 EPS. equities analysts forecast that UnitedHealth Group Inc will post 12.72 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 18th. Investors of record on Friday, September 7th will be issued a dividend of $0.90 per share. The ex-dividend date of this dividend is Thursday, September 6th. This represents a $3.60 dividend on an annualized basis and a yield of 1.36%. UnitedHealth Group’s dividend payout ratio (DPR) is 35.75%.
UnitedHealth Group announced that its Board of Directors has initiated a share repurchase program on Wednesday, June 6th that authorizes the company to buyback 100,000,000 outstanding shares. This buyback authorization authorizes the healthcare conglomerate to buy shares of its stock through open market purchases. Shares buyback programs are often a sign that the company’s board believes its stock is undervalued.
In related news, Director Richard T. Burke sold 20,000 shares of the stock in a transaction dated Wednesday, September 12th. The stock was sold at an average price of $263.41, for a total transaction of $5,268,200.00. Following the sale, the director now owns 1,720,112 shares of the company’s stock, valued at approximately $453,094,701.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Kenneth Irwin Shine sold 177 shares of the stock in a transaction dated Wednesday, July 18th. The stock was sold at an average price of $255.72, for a total value of $45,262.44. Following the sale, the director now directly owns 29,053 shares in the company, valued at approximately $7,429,433.16. The disclosure for this sale can be found here. Insiders have sold a total of 86,603 shares of company stock worth $22,837,660 in the last three months. 0.87% of the stock is currently owned by insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: Hedge Funds – Risk or Reward?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.